BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28716266)

  • 1. Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients.
    Santoro M; Mirabella M; De Fino C; Bianco A; Lucchini M; Losavio F; Sabino A; Nociti V
    J Neurol Sci; 2017 Aug; 379():298-303. PubMed ID: 28716266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition.
    Sophocleous A; Marino S; Kabir D; Ralston SH; Idris AI
    Aging Cell; 2017 Oct; 16(5):1051-1061. PubMed ID: 28752643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia.
    D'Addario C; Micale V; Di Bartolomeo M; Stark T; Pucci M; Sulcova A; Palazzo M; Babinska Z; Cremaschi L; Drago F; Carlo Altamura A; Maccarrone M; Dell'Osso B
    Schizophr Res; 2017 Oct; 188():132-140. PubMed ID: 28108228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.
    Jean-Gilles L; Braitch M; Latif ML; Aram J; Fahey AJ; Edwards LJ; Robins RA; Tanasescu R; Tighe PJ; Gran B; Showe LC; Alexander SP; Chapman V; Kendall DA; Constantinescu CS
    Acta Physiol (Oxf); 2015 May; 214(1):63-74. PubMed ID: 25704169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced humoral immunity in mice lacking CB1 and CB2 receptors (Cnr1-/-/Cnr2-/- mice) is not due to increased splenic noradrenergic neuronal activity.
    Simkins T; Crawford RB; Goudreau JL; Lookingland KJ; Kaplan BL
    J Neuroimmune Pharmacol; 2014 Sep; 9(4):544-57. PubMed ID: 24870806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botanically-Derived Δ
    Fitzpatrick JM; Hackett B; Costelloe L; Hind W; Downer EJ
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice Missing Cnr1 and Cnr2 Show Implantation Defects.
    Li Y; Bian F; Sun X; Dey SK
    Endocrinology; 2019 Apr; 160(4):938-946. PubMed ID: 30776303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression and functional role of cannabinoid genes in alcohol users.
    Agudelo M; Yndart A; Morrison M; Figueroa G; Muñoz K; Samikkannu T; Nair MP
    Drug Alcohol Depend; 2013 Dec; 133(2):789-93. PubMed ID: 24060590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of CNR1 and CNR2 cannabinoid receptors expression levels in COVID-19 patients with and without diabetes mellitus: Recommendations for future research targets.
    Aghamahdi F; Shafiee A; Rostami S; Mokhames Z; Safavi M; Yaslianifard S; Siami Z; Kabir K; Azizi G; Bakhtiyari M; Mozhgani SH
    Diabetes Metab Syndr; 2022 May; 16(5):102499. PubMed ID: 35580523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population.
    Bae JS; Kim JY; Park BL; Kim JH; Kim B; Park CS; Kim BJ; Lee CS; Lee M; Choi WH; Shin TM; Hwang J; Shin HD; Woo SI
    Psychiatr Genet; 2014 Oct; 24(5):225-9. PubMed ID: 25014618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical response to Nabiximols correlates with the downregulation of immune pathways in multiple sclerosis.
    Sorosina M; Clarelli F; Ferrè L; Osiceanu AM; Unal NT; Mascia E; Martinelli V; Comi G; Benigni F; Esposito F; Martinelli Boneschi F
    Eur J Neurol; 2018 Jul; 25(7):934-e70. PubMed ID: 29528549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal.
    Navarrete F; Aracil-Fernández A; Manzanares J
    Br J Pharmacol; 2018 Jul; 175(13):2676-2688. PubMed ID: 29624642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of cannabinoid receptor genes (
    Peiró AM; García-Gutiérrez MS; Planelles B; Femenía T; Mingote C; Jiménez-Treviño L; Martínez-Barrondo S; García-Portilla MP; Saiz PA; Bobes J; Manzanares J
    Anxiety Stress Coping; 2020 May; 33(3):256-265. PubMed ID: 32114795
    [No Abstract]   [Full Text] [Related]  

  • 14. The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ9-tetrahydrocannabinol acting through CB1 receptors.
    Moreno-Martet M; Feliú A; Espejo-Porras F; Mecha M; Carrillo-Salinas FJ; Fernández-Ruiz J; Guaza C; de Lago E
    Mult Scler Relat Disord; 2015 Nov; 4(6):505-11. PubMed ID: 26590655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daytime-Dependent Changes of Cannabinoid Receptor Type 1 and Type 2 Expression in Rat Liver.
    Bazwinsky-Wutschke I; Zipprich A; Dehghani F
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis.
    Centonze D; Mori F; Koch G; Buttari F; Codecà C; Rossi S; Cencioni MT; Bari M; Fiore S; Bernardi G; Battistini L; Maccarrone M
    Neurol Sci; 2009 Dec; 30(6):531-4. PubMed ID: 19768368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis.
    Gajofatto A
    Mult Scler Relat Disord; 2016 Jul; 8():64-5. PubMed ID: 27456876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cannabinoid receptors and RAGE in inflammatory bowel disease.
    Stintzing S; Wissniowski TT; Lohwasser C; Alinger B; Neureiter D; Ocker M
    Histol Histopathol; 2011 Jun; 26(6):735-45. PubMed ID: 21472688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells.
    Damiano S; Sasso A; De Felice B; Terrazzano G; Bresciamorra V; Carotenuto A; Orefice NS; Orefice G; Vacca G; Belfiore A; Santillo M; Mondola P
    Brain Res Bull; 2015 Sep; 118():1-6. PubMed ID: 26327496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of DNA methylation genes in secondary progressive multiple sclerosis.
    Fagone P; Mangano K; Di Marco R; Touil-Boukoffa C; Chikovan T; Signorelli S; Lombardo GA; Patti F; Mammana S; Nicoletti F
    J Neuroimmunol; 2016 Jan; 290():66-9. PubMed ID: 26711572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.